Quality of life measures

Quality of Life Measures in Clinical Trials

Quality of Life (QoL) measures evaluate the impact of a medical condition or treatment on a patient’s overall well-being, beyond traditional clinical endpoints such as survival or symptom control. These measures are essential in trials where patient-centered outcomes are critical, especially in chronic illness, cancer, mental health, and palliative care.

What is Quality of Life?

QoL refers to a multidimensional concept that includes:

• Physical well-being (e.g., fatigue, pain)
• Psychological health (e.g., anxiety, depression)
• Social functioning (e.g., relationships, support)
• Functional status (e.g., ability to perform daily tasks)

When measured in health research, it’s often referred to as Health-Related Quality of Life (HRQoL).

Why Include QoL Measures in Clinical Trials?

There are several important reasons to include Quality of Life (QoL) measures in clinical trials. First, they allow for a more holistic evaluation of treatment by capturing the impact beyond biological or clinical markers, such as how a patient feels or functions in daily life. Second, they promote patient-centered research, ensuring that outcomes reflect what matters most to patients—not just clinicians or researchers.

QoL measures also enhance benefit-risk assessment by helping weigh adverse effects against perceived benefits from the patient's perspective. In addition, they inform decision-making, supporting shared choices between patients and healthcare providers based on real-world impacts. Finally, QoL data are increasingly used to support regulatory and reimbursement decisions, as agencies and payers look beyond clinical efficacy to consider the broader value of interventions.

Commonly Used QoL Instruments

Generic Instruments (Applicable across a wide range of conditions):

• SF-36 / SF-12: Short Form Health Survey
• EQ-5D: EuroQol five-dimension scale
• WHOQOL: World Health Organization Quality of Life instruments

Disease-Specific Instruments (Tailored to specific conditions):

• EORTC QLQ-C30 (for cancer)
• FACT-G (Functional Assessment of Cancer Therapy – General)
• AQLQ (Asthma Quality of Life Questionnaire)
• MSQoL-54 (Multiple Sclerosis QoL)

Design Considerations When Using QoL Measures

1. Instrument Selection
   1. Is the tool validated in the target population and language?
   2. Does it measure the relevant domains of QoL for the condition?
2. Timing of Measurement
   1. Baseline, follow-up, and long-term assessment are key
   2. Consider trial duration and expected changes in QoL over time
3. Mode of Administration
   1. Paper-based, electronic (ePRO), or interview
   2. Must ensure accessibility and data quality
4. Handling Missing Data
   1. Missing QoL data is common—plan appropriate imputation methods
   2. Use sensitivity analyses
5. Statistical Analysis
   1. Use of summary scores, responder definitions, or area-under-curve (AUC) approaches
   2. Adjust for baseline QoL and handle skewed distributions

Interpreting QoL Outcomes

• Clinically meaningful difference (e.g., Minimal Important Difference or MID) is key for interpretation
• Effects should be reported with confidence intervals, and visualized where possible (e.g., line graphs over time)
• Researchers should distinguish between statistical significance and clinical relevance

Regulatory and Reporting Guidelines

• Follow SPIRIT-PRO (for protocol design) and CONSORT-PRO (for reporting) when QoL is a primary or secondary outcome
• Register QoL measures in advance on platforms like ClinicalTrials.gov or other trial registries

Conclusion

Incorporating quality of life measures in clinical trials ensures that research reflects the lived experiences of participants. By capturing how treatments affect physical, emotional, and social well-being, QoL data adds depth, meaning, and relevance to clinical evidence.

---

Adapted for educational use. Consult regulatory guidance (e.g., FDA, EMA) and PRO-specific resources when designing studies with QoL outcomes.